Quest Diagnostics, Lyndhurst, N.J., signed a definitive agreement to buy LabOne, a Lenexa, Kan.-based provider of health screening and risk assessment to insurance companies, for $934 million in cash, according to a statement from the two companies. LabOne also provides clinical diagnostic testing to healthcare providers and drug testing to employers. The deal, expected to close in the final three months of this year, would provide annual savings of $30 million to the company after LabOne is integrated into Quest, according to the statement. -- by Paul Barr
Quest to purchase LabOne for $934 million
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.